Inventor · disambiguated record
Robert F. Kaltenbach, Iii
Also filed as: KALTENBACH III ROBERT F · KALTENBACH III ROBERT FRANK · KALTENBACH ROBERT F
28 granted patents·4 pending applications·152 citations·filing 1993–2024
95Inventor score
Files withBRISTOL MYERS SQUIBB CO21BRISTOL MYERS SQUIBB PHARMA CO4DU PONT MERCK PHARMA3DU PONT PHARM CO2BRISTOL MEYERS SQUIBB CO1
Top patents by PatentIndex Score
32 records- 0198US10662172B2Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 26, 2020·30 cites·121 claims
- 0297US10576062B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 3, 2020·18 cites·18 claims
- 0396US10071078B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·21 cites·16 claims
- 0494US11007180B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 18, 2021·3 cites·1 claims
- 0588US11180488B2Isoxazole o-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 23, 2021·4 cites·28 claims
- 0688US2025057815A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0787US7547782B2Met kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 16, 2009·6 cites·17 claims
- 0886US12195444B2Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jan 14, 2025·0 cites·20 claims
- 0986US11447475B2Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 20, 2022·3 cites·18 claims
- 1086US2023390249A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1182US7045540B2Selective estrogen receptor modulatorsBRISTOL MEYERS SQUIBB CO·Filed 2005·Granted May 16, 2006·4 cites·21 claims
- 1281US11267800B2Cyclohexyl acid triazole azines as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 8, 2022·2 cites·31 claims
- 1381US6391919B1Bis-amino acid sulfonamides containing substituted benzyl amines HIV protease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 21, 2002·11 cites·24 claims
- 1479US2022249443A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1575US2021244711A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1673USRE49352ECarbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 3, 2023·0 cites·25 claims
- 1772US11697646B2Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 11, 2023·0 cites·20 claims
- 1870US6927224B2Selective estrogen receptor modulatorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Aug 9, 2005·3 cites·9 claims
- 1970US6528681B2Halogenated triphenylethylene derivatives as selective estrogen receptor modulatorsBRISTOL MEYERS SQUIBB PHARMA C·Filed 2001·Granted Mar 4, 2003·5 cites·6 claims
- 2070US5376664AUnsymmetrical mono-3-nitro bis-naphthalimides as anticancer agentsDU PONT MERCK PHARMA·Filed 1993·Granted Dec 27, 1994·11 cites·8 claims
- 2169US11008300B2Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 18, 2021·0 cites·24 claims
- 2267US5932570A1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitorsDU PONT PHARM CO·Filed 1997·Granted Aug 3, 1999·11 cites·17 claims
- 2357US7323587B2Selective estrogen receptor modulatorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Jan 29, 2008·0 cites·13 claims
- 2457US5416089APolycyclic and heterocyclic chromophores for bis-imide tumoricidalsDU PONT MERCK PHARMA·Filed 1993·Granted May 16, 1995·12 cites·15 claims
- 2556US12384768B2Isoxazole carboxylic acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 12, 2025·0 cites·12 claims
- 2654US6617310B2Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl aminesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Sep 9, 2003·0 cites·30 claims
- 2753US12466804B2Cyclobutyl carboxylic acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 11, 2025·0 cites·12 claims
- 2853US12435057B2Triazole carboxylic acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 7, 2025·0 cites·21 claims
- 2951US6562848B1Bis-amino acid sulfonamides as HIV protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 13, 2003·0 cites·20 claims
- 3049US12209072B2Cyclopentyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 28, 2025·0 cites·20 claims
- 3147US5585382APolycyclic and heterocyclic chromophores for bis-imide tumoricidalsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 17, 1996·7 cites·14 claims
- 3239US5880295AProcess for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitorsDU PONT PHARM CO·Filed 1996·Granted Mar 9, 1999·1 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Robert F. Kaltenbach, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →